Beckman Coulter Life Sciences, laboratory automation and innovation specialists, has launched its new IR820 and IR870 infrared dye antibody conjugates, created to provide research ...

GNQ Insilico (GNQ), a TechBio firm leveraging exponential technologies for precision medicine, launched its deep tech Drug Assessment Platform (DAP). This system combines artificial intelligence with ...

A biohybrid system, capable of mimicking the biological interface between bones and muscles, has been developed by ...

Researchers have identified specific nerve pathways responsible for relaying pain signals from the bowel to the brain, enabling researcher into new treatments for irritable bowel syndrome (IBS) and ...

An international team of scientists have shared how rogue rings of DNA that float outside of our chromosomes, known as ...

Körber is broadening its network in the Human Machine Interfaces (HMI) sector by partnering with Pepperl+Fuchs, a provider of ...

An international team of scientists have shared how rogue rings of DNA that float outside of our chromosomes, known as ...

The research team is a multidisciplinary partnership that includes academic AI researchers from Old Dominion University, AD scientists from the University of Pennsylvania and Sanford Burnham Prebys, ...

Tom Harrison of Solving MS said, “We’re thrilled to partner with BIC and collaborate with like-minded scientists, clinicians, and advocates. Together, we can accelerate the path to effective therapies ...

Traditional drug discovery has long focused on developing inhibitors that block the function of disease-related proteins by occupying their active sites. However, this approach leaves a significant ...

German liquid handling expert Brand has launched the Transferpette Pro micropipette. The Transferpette Pro offers one-handed operation, volume-change protection, and ergonomic design. The slim design ...

Transcription factors (TFs) are central regulators of gene expression and are implicated in numerous diseases, including cancer, autoimmune, neurological, and metabolic disorders. Once considered ...